Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Antibiotic resistance » Page 2

Antibiotic resistance


Check out the latest antibiotic resistance news and antimicrobial resistance news. This section covers the latest biotech advancements to tackle antibiotic resistance.

ADVERTISEMENT
News and Trends

Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic

Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…

By Clara Rodríguez Fernández
January 3, 2020 - 2 minutes
News and Trends

Iterum Therapeutics Reels from Antibiotic Phase III Fail

An antibiotic candidate developed by the Irish company Iterum Therapeutics has failed to meet the…

By Jonathan Smith
December 12, 2019 - 2 minutes
News and Trends

EU Court Ushers in the Use of Phages Against Listeria in Food

Amidst recent listeria outbreaks in Europe, the European Court of Justice has issued a court…

By Clara Rodríguez Fernández
October 25, 2019 - 3 minutes
News and Trends

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day…

By Jonathan Smith
October 22, 2019 - 3 minutes
News and Trends

UK Biotech to Fight Antibiotic-Resistant Bacteria with €8M Grant

The UK biotech Procarta Biosystems has received a grant worth up to €8.3M from the…

By Jonathan Smith
September 17, 2019 - 2 minutes
News and Trends

US Genomics Firm Combines with Curetis to Tackle Antibiotic Resistance

The German biotech Curetis has been combined with the US genomics company OpGen to pool…

By Jonathan Smith
September 4, 2019 - 3 minutes
News and Trends

Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic

The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…

By Helen Albert
August 20, 2019 - 3 minutes
More News!

Swiss Pneumonia Antibiotic Abandoned in Phase III

The Swiss biotech Polyphor has discontinued two phase III trials of its antibiotic for treating…

By Jonathan Smith
July 18, 2019 - 2 minutes
More News!

Scientists in Belgium Cure Anthrax in Mice by Smashing Bacteria’s Armor

Belgian researchers have developed a potential treatment for anthrax that breaks down the bacteria’s thick…

By Jonathan Smith
July 17, 2019 - 2 minutes
More News!

Evotec to Reduce the Burden of Tuberculosis Treatment with €21M Grant

The Bill and Melinda Gates Foundation has granted the German biotech Evotec €21M ($23.8M) to…

By Jonathan Smith
June 12, 2019 - 2 minutes
News and Trends

€25M European Loan to Fund Diagnostics Tackling Antibiotic Resistance

The Finnish biotech Mobidiag has received a loan of €25M from the European Investment Bank…

By Jonathan Smith
May 15, 2019 - 2 minutes
News and Trends

Swiss Biotech Halts Pneumonia Antibiotic Trial After Patient Safety Scare

Polyphor has temporarily halted two phase III trials of an antibiotic treating pneumonia, after an…

By Jonathan Smith
May 10, 2019 - 3 minutes
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast